Animal Pharm is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


US approves SP acquisition of Organon BioSciences

The US Federal Trade Commission has approved Schering-Plough's acquisition of Organon BioSciences, the parent company of Intervet. To allay competitive concerns, Schering-Plough will be required to divest three of its poultry vaccines in the US. In October, the company agreed to divest twenty products as a condition of approval from the European Commission (Animal Pharm No 624, p 1). Schering-Plough said the divestitures will not have a significant impact on the company's financial results.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts